We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current BPTH market cap is 3.15M. The company's latest EPS is USD -3.7331 and P/E is -0.20.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.28M | -3.03M | -3.7M | -3.04M | -2.63M |
| Net Income | -3.2M | -3.37M | -3.16M | -1.87M | -2.12M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 10.44M | 0 | 0 |
| Operating Income | -8.69M | -10.91M | 0 | -13.9M | -15.84M |
| Net Income | -8.6M | -10.88M | 21.65M | -13.87M | -16.08M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 5.02M | 3.22M | 1.77M | 5.12M | 2.97M |
| Total Liabilities | 2.5M | 2.78M | 4.39M | 3.83M | 3.68M |
| Total Equity | 2.53M | 441k | -2.63M | 1.29M | -712k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 22.66M | 16.48M | 26.57M | 15.97M | 3.22M |
| Total Liabilities | 1.57M | 1.41M | 1.11M | 1.8M | 2.78M |
| Total Equity | 21.09M | 15.07M | 25.46M | 14.17M | 441k |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.72M | -11.54M | -1.04M | -4.27M | -7.69M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 1.69M | 2.2M | 174k | 7.22M | 7.2M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.36M | -10.96M | -9.92M | -15.1M | -11.54M |
| Investing | N/A | N/A | -70k | -21k | N/A |
| Financing | 27.78M | 4.29M | 20.01M | 1.73M | 2.2M |
| Market Cap | 3.15M |
| Price to Earnings Ratio | -0.20 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.99 |
| Price to Book Ratio | 7.13 |
| Dividend Yield | - |
| Shares Outstanding | 4.31M |
| Average Volume (1 week) | 76.09k |
| Average Volume (1 Month) | 136.93k |
| 52 Week Change | -91.73% |
| 52 Week High | 9.9875 |
| 52 Week Low | 0.593263 |
| Spread (Intraday) | 0.04 (4.74%) |
| Company Name | Bio Path Holdings Inc |
| Address |
108 lakeland ave dover, delaware 19901 |
| Website | https://www.biopathholdings.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
